Login to Your Account



Isolagen Offering Raises $59.5M For Autologous Cellular Therapies

By Karen Pihl-Carey


Friday, June 11, 2004
Tissue-regeneration company Isolagen Inc. brought in $59.5 million in a follow-on offering Thursday, leaving it with wrinkle-free plans to begin pivotal trials and bring its lead anti-aging product to the market. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription